Casdin Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

Casdin Capital’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-225,000	Closed	-$1.38M	–	55
2021 Q3	$1.38M	Sell	225,000 -275,000	-55%	-$2.19M	0.03%	53
2021 Q2	$5.05M	Buy	+500,000	New	+$5.42M	0.13%	49

Other funds holding NAUT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return